Jaguar Health designates 300 shares of Series P non-convertible preferred stock

Jaguar Health's board authorized the issuance of Series P non-convertible preferred stock with 300 shares designated. The filing establishes terms and conditions for this new preferred stock class, potentially indicating capital raising activity.